- Front Page
- Registrant group for Cetrimonium Bromide (CTAB)
- Registrant group for Reaction mass of C12 trimethylammonium bromide and C14 trimethylammonium bromide
- Registrant group for Tetradonium Bromide
- Why us
- Download & Publications
- Contact us
The Bioprocessing Summit
World Biosimilar Congress
The 2017 Bioprocessing Summit will be held 13-16 August in Boston, MA at the Sheraton Boston.
This summit convenes more than 1,000 international bioprocess professionals to share practical solutions for today’s bioprocess challengesThe congress is a commercially focused event bringing together the full value chain and looks at commercializing and pushing forward the adoption of biosimilars globally.
We at Novo Nordisk Pharmatech invite you to come visit our both (booth #108) to discover more about recombinant insulin for innovative biologics and pharmaceutical grade Quaternary ammonium compounds.
At Novo Nordisk Pharmatech we remain the leading worldwide supplier of recombinant insulin. Our recombinant insulin is a key component in serum free growth media for mammalian cells and approved by regulatory bodies worldwide, including FDA and EMA, and our products are manufactured to cGMP standards, and we guarantee:
- Global regulatory compliance
- Consistent high quality
- Extensive regulatory documentation
- Continuous availability
- Secure global supply chain
- High levels of service and support
We deliver a proven record of product Purity, Reliability and Consistency and can even tailor Quality products for future therapies.
Increase viable CHO cell density in commercial available cell culture medium by supplementation with non-animal insulin
CHO cells are one of the most widely used platforms for the production of biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media from Serum containing to Serum free and further on to chemically defined media. UAB in collaboration with Novo Nordisk Pharmatech (world’s largest supplier of recombinant insulin) has shown that addition of animal origin free insulin to three leading commercially available off-the-shelf chemically defined media resulted in significant increases in viable cell density. In addition to this benefit insulin has been proven to aid in the expression of difficult to express proteins. Please stop by our booth for a talk how insulin could play an important role in your upstream process and for the chance to win an Amazon kindle.
If you want to learn more about our recombinant Insulin Human click here
We look forward to see you at our both and offer you a chance to discover more about our recombinant insulin for innovative biologics.